| Serial Number | 88330079 |
| Word Mark | ENZYVANT |
| Filing Date | Thursday, March 7, 2019 |
| Status | 700 - REGISTERED |
| Status Date | Tuesday, June 9, 2020 |
| Registration Number | 6072404 |
| Registration Date | Tuesday, June 9, 2020 |
| Mark Drawing | 3000 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s) |
| Published for Opposition Date | Tuesday, March 24, 2020 |
| Indication of Colors claimed | Color is not claimed as a feature of the mark. |
| Description of Mark | The mark consists of a design of ovals forming two concentric circles with the wording "ENZYVANT" appearing to the right of the design. |
| Goods and Services | Pharmaceutical preparations for human use for the treatment of rare or metabolic, acid ceramidase deficiency, pediatric congenital athymia and thymus gland diseases, disorders and conditions, and immune deficiency related thereto; pharmaceutical preparations for human use, namely, tissue-based regenerative therapy to treat pediatric congenital athymia and thymus gland diseases, disorders and conditions, and immune deficiency related thereto; biologic preparations for medical and therapeutic purposes for the treatment of rare or metabolic, acid ceramidase deficiency, pediatric congenital athymia and thymus gland diseases, disorders and conditions, and immune deficiency related thereto; biologic preparations for medical and therapeutic purposes, namely, tissue-based regenerative therapy to treat pediatric congenital athymia and thymus gland diseases, disorders and conditions, and immune deficiency related thereto |
| Goods and Services | Scientific and technological services, namely, medical research, scientific research and analysis in the fields of pharmaceuticals and biomedicine; pharmaceutical, biomedical and biological therapeutic research services; scientific research in the fields of pharmaceutical and biologic therapeutic preparations, clinical trials and post-market clinical trials; pharmaceutical research and development; providing scientific research information in the fields of pharmaceuticals, biomedicine, clinical trials and post-market clinical trials |
| Goods and Services | Providing health and medical information; providing information relating to the diagnostic, prophylactic and therapeutic properties of pharmaceutical preparations and biologic preparations for the prevention and treatment of diseases, disorders and conditions |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Tuesday, March 26, 2019 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Tuesday, March 26, 2019 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Tuesday, March 26, 2019 |
| Primary Code | 044 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | Enzyvant Therapeutics GmbH |
| Party Type | 30 - Original Registrant |
| Legal Entity Type | 99 - Other |
| Address | Basel 4051 CH |
| Party Name | Enzyvant Therapeutics GmbH |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 99 - Other |
| Address | Basel 4051 CH |
| Party Name | Enzyvant Therapeutics GmbH |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 99 - Other |
| Address | Basel 4051 CH |
| Event Date | Event Description |
| Tuesday, June 9, 2020 | REGISTERED-PRINCIPAL REGISTER |
| Tuesday, March 24, 2020 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, March 24, 2020 | PUBLISHED FOR OPPOSITION |
| Wednesday, March 4, 2020 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Wednesday, February 19, 2020 | LAW OFFICE PUBLICATION REVIEW COMPLETED |
| Monday, February 10, 2020 | ASSIGNED TO LIE |
| Friday, January 31, 2020 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Friday, January 31, 2020 | PREVIOUS ALLOWANCE COUNT WITHDRAWN |
| Friday, January 31, 2020 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Monday, January 27, 2020 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Sunday, January 26, 2020 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Sunday, January 26, 2020 | TEAS REQUEST FOR RECONSIDERATION RECEIVED |
| Saturday, January 25, 2020 | NOTIFICATION OF FINAL REFUSAL EMAILED |
| Saturday, January 25, 2020 | FINAL REFUSAL E-MAILED |
| Saturday, January 25, 2020 | FINAL REFUSAL WRITTEN |
| Thursday, November 14, 2019 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Wednesday, November 13, 2019 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Wednesday, November 13, 2019 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Thursday, July 25, 2019 | ASSIGNED TO EXAMINER |
| Saturday, May 18, 2019 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Saturday, May 18, 2019 | NON-FINAL ACTION E-MAILED |
| Saturday, May 18, 2019 | NON-FINAL ACTION WRITTEN |
| Thursday, May 9, 2019 | ASSIGNED TO EXAMINER |
| Wednesday, March 27, 2019 | NOTICE OF DESIGN SEARCH CODE E-MAILED |
| Tuesday, March 26, 2019 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM |
| Monday, March 11, 2019 | NEW APPLICATION ENTERED IN TRAM |